Close Menu

SNP arrays

Chromsomal array testing had a higher diagnostic yield in the study than standard procedures, and could have value as a first step before referring patients to further tests.

23andMe has seen a rebound in its ancestry testing business, and hopes that it will be able to return health information to US customers by the year end.

Thanks to a new array, NatGeo will now offer customers expanded Y chromosome and mtDNA analyses, setting it apart in a competitive consumer genomics market.

AncestryHealth is a new online resource that the family history company hopes will blossom into a larger business segment devoted exclusively to health.

The results confirm in the context of normal clinical practice what earlier studies saw in research populations, solidifying the prognostic role of cnLOH independent of other measures.

Researchers used SNP arrays to find that separate samples from the same tumors and from primary and metastatic tumors in children were highly genomically diverse.

CombiMatrix has jumped into the IVF market with a new preimplantantion genetic screening test service for women. The launch extends its business beyond the array-based pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis markets.

NEW YORK (GenomeWeb) – In Nature Genetics, an international team led by investigators in the US, UK, Netherlands, and Belgium described half a dozen new loci linked to the lung volume-related t

NEW YORK (GenomeWeb News) – In Nature Genetics, an international team led by investigators at the University of Michigan, the Broad Institute, and Massachusetts General Hospital presented a computa

NEW YORK (GenomeWeb News) – In a study (pdf) in press in eLife, a Harvard University-led team presented findings from their research on mice missing a dozen-and-a-half different

Pages

Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.

The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.

The Biden Administration is investing $1.7 billion to detect and monitor SARS-CoV-2 variants.

In PLOS this week: genome instability in Aicardi-Goutières Syndrome, introduction of SARS-CoV-2 to the Colombian Amazon, and more.